Aurinia Pharmaceuticals (AUPH) Asset Utilization Ratio (2021 - 2026)

Aurinia Pharmaceuticals has reported Asset Utilization Ratio for 6 years, with the latest figure at 0.4 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 13.72% year-over-year to 0.4; the trailing twelve-month figure through Mar 2026 stood at 0.4 (down 13.72% YoY), and the FY2025 full-year result was 0.43, up 1.57% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.4, down from 0.44 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.52 in Q2 2025, with the low at 0.13 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.36 across 5 years, with a median of 0.36 in 2024.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio jumped 176.82% — and 2026, when it dropped 13.72%.
• Aurinia Pharmaceuticals' Asset Utilization Ratio stood at 0.28 in 2022, then gained by 13.86% to 0.32 in 2023, then soared by 34.34% to 0.43 in 2024, then advanced by 3.52% to 0.44 in 2025, then fell by 8.65% to 0.4 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.4 (Q1 2026), 0.44 (Q4 2025), and 0.52 (Q3 2025), per Business Quant data.